Physician profile
David C Nelson
NPI 1932631934
$765.76
in general payments reported to CMS, 2019-2025
14 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.13 · 2022: $300 · 2023: $75.95 · 2024: $172 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $238.92 | 2022 | |
| Biogen, INC. | $193.23 | 2024-2025 | Zurzuvae |
| Organon LLC | $95.10 | 2023-2024 | Nexplanon |
| Abbvie INC. | $48.66 | 2021-2022 | |
| Exeltis, USA INC. | $35.06 | 2021 | |
| Astellas Pharma US INC | $25.70 | 2025 | Veozah |
| Agile Therapeutics, INC. | $18.53 | 2023 | Twirla |
| Therapeuticsmd, INC. | $18.45 | 2022 | |
| Dexcom, INC. | $17.25 | 2024 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $16.28 | 2023 | Third Wave, Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $15.68 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $14.63 | 2022 | |
| Shield Therapeutics INC | $14.24 | 2024 | |
| Coopersurgical, INC. | $14.03 | 2023 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.